Therefore, more studies on the miRNA-induced ABCB1 or ABCG2 expression, which leads to drug resistance in ovarian cancer, will improve our understanding of the drug resistance mechanism of ABC transporters. This evidence concerns the gene ABCB1 and ovarian cancer.